ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, BOTH ASSOCIATED WITH LONG-TERM RENAL OUTCOMES IN IGA NEPHROPATHY: 36-WEEK RESULTS FROM THE PHASE 2B ORIGIN STUDY

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-1294, Poster Board= SUN-038

Jonathan Barratt Poster Presenter